Skip to main content
logo
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
447.72
+6.56 (1.49%)
Mar 23, 2026, 4:00 PM EDT - Market closed

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
10,27113,3026,7904,5995,2541,449
Market Cap Growth
41.48%95.90%47.65%-12.47%262.53%-15.93%
Enterprise Value
9,63512,6655,9824,0814,9451,179
Last Close Price
447.72582.34308.57231.38290.2584.74
PE Ratio
--45.32-14.09-11.57-16.85-5.79
PS Ratio
10.7213.8837.69---
PB Ratio
16.9722.079.0011.3526.627.39
P/TBV Ratio
16.6721.688.7010.6725.207.15
P/FCF Ratio
--70.00-14.86-14.12-23.34-7.87
P/OCF Ratio
--70.17-14.90-14.18-23.37-7.88
EV/Sales Ratio
10.0513.2133.21---
EV/EBITDA Ratio
--42.42-12.04-10.74-16.87-4.87
EV/EBIT Ratio
--42.20-12.02-10.73-16.84-4.86
EV/FCF Ratio
--66.65-13.09-12.53-21.97-6.41
Debt / Equity Ratio
0.580.580.160.290.250.00
Debt / EBITDA Ratio
-1.16-1.16-0.24-0.31-0.170.00
Debt / FCF Ratio
-1.83-1.83-0.26-0.36-0.220.00
Net Debt / Equity Ratio
-1.05-1.05-1.07-1.27-1.56-1.37
Net Debt / EBITDA Ratio
2.132.131.621.361.051.11
Net Debt / FCF Ratio
3.353.351.771.591.371.46
Asset Turnover
0.830.830.21000
Inventory Turnover
1.031.030.37---
Quick Ratio
3.603.605.795.353.103.52
Current Ratio
4.014.016.105.383.123.54
Return on Equity (ROE)
-42.49%-42.49%-80.35%-123.98%-150.12%-110.92%
Return on Assets (ROA)
-26.07%-26.07%-59.17%-75.86%-92.33%-86.55%
Return on Invested Capital (ROIC)
701.67%701.67%607.52%341.10%317.48%415.08%
Return on Capital Employed (ROCE)
-32.94%-32.94%-71.38%-99.00%-132.49%-110.99%
Earnings Yield
-2.81%-2.21%-7.10%-8.64%-5.94%-17.26%
FCF Yield
-1.85%-1.43%-6.73%-7.08%-4.28%-12.70%
Buyback Yield / Dilution
-0.29%-0.29%-10.83%-11.54%-5.03%-11.81%
Updated Feb 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q